InsiderTrades

Form 4 for MRSH Marsh McLennan

Accepted 2025-12-02 00:00:00 ET · period of report 2025-12-01 · accession 0000062709-25-000143 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-12-02 2025-12-01 MRSH Doyle John Q Pres, CEO S - Sale+OE $182.22 -21.1K 87.7K -19% -$3.84M
D 2025-12-02 2025-12-01 MRSH Doyle John Q Pres, CEO M - OptEx $63.09 +21.1K 108.8K +24% +$1.33M
D 2025-12-02 2025-12-01 MRSH Doyle John Q Pres, CEO M - OptEx $0.00 -21.1K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-12-01 S D 21,079 $182.22 87,681.02 D — —
2 Common Common Stock 2025-12-01 M A 21,079 $63.09 108,760.02 D — —
3 Derivative Stock Options (Right to Buy) 2025-12-01 M D 21,079 $0.00 0 D $63.09 · — to 2026-04-30 21,079 Common Stock (F2) These options were granted on May 1, 2016 and vested in four equal annual installments on May 1st of 2017, 2018, 2019 and 2020.